Obat
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Obat?
Obat is currently owned by Truffle Capital through Truffle Financial Innovation Fund (2019 vintage), since 2022. Across its history, Obat has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Truffle CapitalTruffle Financial Innovation Fund · 2019 · VC
5 ownership periods · full history below
Key facts
HQFrance
SectorTechnology
Key takeaways
- ·Co-held by Truffle Capital, Crédit Mutuel Equity, Crédit Mutuel Innovation and Evolem since 2022.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected · 1 lender on file
Active
Co-invest · 4 holders · 2022 · present
Truffle CapitalActive
2022 · present(4yr) · Truffle Financial Innovation Fund · 2019 · VC
EvolemActive
2023 · present(3yr) · Evolem Start · 2015 · VC
Crédit Mutuel InnovationActive
2023 · present(3yr) · Crédit Mutuel Innovation Evergreen Capital · 2004 · Evergreen
Crédit Mutuel EquityActive
2023 · present(3yr) · Crédit Mutuel Equity · 1992 · Growth
More from Truffle Financial Innovation Fund
Other portfolio companies in the same fund.
Switzerland
BelgiumMore PE-backed in SaaS
Comparable saas deals from other GPs.
UK
US
Ireland
Track Obat
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Obat?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Obat.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue